Abstract
The currently used serological subtyping scheme for the pathogen Neisseria meningitidis is not comprehensive, a proportion of isolates are reported as not subtypeable (NST), and few isolates are fully characterized with two subtypes for each strain. To establish the reasons for this and to assess the effectiveness of DNA-based subtyping schemes, dot blot hybridization and nucleotide sequence analyses were used to characterize the genes encoding antigenic variants of the meningococcal subtyping antigen, the PorA protein. A total of 233 strains, including 174 serologically NST and 59 partially or completely subtyped meningococcal strains, were surveyed. The NST isolates were chosen to be temporally and geographically representative of NST strains, isolated in England and Wales, and submitted to the Meningococcal Reference Unit in the period 1989 to 1991. The DNA-based analyses demonstrated that all of the strains examined possessed a porA gene. Some of these strains were serologically NST because of a lack of monoclonal antibodies against certain PorA epitopes; in other cases, strains expressed minor variants of known PorA epitopes that did not react with monoclonal antibodies in serological assays. Lack of expression remained a possible explanation for serological typing failure in some cases. These findings have important implications for epidemiological analysis and vaccine design and demonstrate the need for genetic characterization, rather than phenotypic characterization using monoclonal antibodies, for the identification of meningococcal strains.
Full Text
The Full Text of this article is available as a PDF (236.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abdillahi H., Poolman J. T. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb Pathog. 1988 Jan;4(1):27–32. doi: 10.1016/0882-4010(88)90045-9. [DOI] [PubMed] [Google Scholar]
- BRANHAM S. E. Serological relationships among meningococci. Bacteriol Rev. 1953 Sep;17(3):175–188. doi: 10.1128/br.17.3.175-188.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bjune G., Høiby E. A., Grønnesby J. K., Arnesen O., Fredriksen J. H., Halstensen A., Holten E., Lindbak A. K., Nøkleby H., Rosenqvist E. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet. 1991 Nov 2;338(8775):1093–1096. doi: 10.1016/0140-6736(91)91961-s. [DOI] [PubMed] [Google Scholar]
- Brooks J. L., Fallon R. J., Heckels J. E. Sequence variation in class 1 outer membrane protein in Neisseria meningitidis isolated from patients with meningococcal infection and close household contacts. FEMS Microbiol Lett. 1995 May 1;128(2):145–150. doi: 10.1111/j.1574-6968.1995.tb07514.x. [DOI] [PubMed] [Google Scholar]
- Brunham R. C., Plummer F. A., Stephens R. S. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun. 1993 Jun;61(6):2273–2276. doi: 10.1128/iai.61.6.2273-2276.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bygraves J. A., Maiden M. C. Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis. J Gen Microbiol. 1992 Mar;138(3):523–531. doi: 10.1099/00221287-138-3-523. [DOI] [PubMed] [Google Scholar]
- Cartwright K. A., Stuart J. M., Jones D. M., Noah N. D. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 1987 Dec;99(3):591–601. doi: 10.1017/s0950268800066449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Christodoulides M., McGuinness B. T., Heckels J. E. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide. J Gen Microbiol. 1993 Aug;139(8):1729–1738. doi: 10.1099/00221287-139-8-1729. [DOI] [PubMed] [Google Scholar]
- Delvig A., Jahn S., Kusecek B., Heckels J. E., Rosenqvist E., Høiby E. A., Michaelsen T. E., Achtman M. A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis. Mol Immunol. 1994 Nov;31(16):1257–1267. doi: 10.1016/0161-5890(94)90076-0. [DOI] [PubMed] [Google Scholar]
- Embley T. M. The linear PCR reaction: a simple and robust method for sequencing amplified rRNA genes. Lett Appl Microbiol. 1991 Sep;13(3):171–174. doi: 10.1111/j.1472-765x.1991.tb00600.x. [DOI] [PubMed] [Google Scholar]
- Feavers I. M., Heath A. B., Bygraves J. A., Maiden M. C. Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis. Mol Microbiol. 1992 Feb;6(4):489–495. doi: 10.1111/j.1365-2958.1992.tb01493.x. [DOI] [PubMed] [Google Scholar]
- Frasch C. E. Vaccines for prevention of meningococcal disease. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S134–S138. doi: 10.1128/cmr.2.suppl.s134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frasch C. E., Zollinger W. D., Poolman J. T. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis. 1985 Jul-Aug;7(4):504–510. doi: 10.1093/clinids/7.4.504. [DOI] [PubMed] [Google Scholar]
- Jones D. M., Kaczmarski E. B. Meningococcal infections in England and Wales: 1991. Commun Dis Rep CDR Rev. 1992 May 22;2(6):R61–R63. [PubMed] [Google Scholar]
- Jones D. M., Kaczmarski E. B. Meningococcal infections in England and Wales: report of the Meningococcal Reference Laboratory for 1990. CDR (Lond Engl Rev) 1991 Jun 21;1(7):R76–R78. [PubMed] [Google Scholar]
- Kellogg D. S., Jr, Turner E. M. Rapid fermentation confirmation of Neisseria gonorrhoeae. Appl Microbiol. 1973 Apr;25(4):550–552. doi: 10.1128/am.25.4.550-552.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lepow M. L., Goldschneider I., Gold R., Randolph M., Gotschlich E. C. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics. 1977 Nov;60(5):673–680. [PubMed] [Google Scholar]
- Lifely M. R., Roberts S. C., Shepherd W. M., Esdaile J., Wang Z., Cleverly A., Aulaqi A. A., Moreno C. Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins. Vaccine. 1991 Jan;9(1):60–66. doi: 10.1016/0264-410x(91)90318-z. [DOI] [PubMed] [Google Scholar]
- Maiden M. C., Bygraves J. A., McCarvil J., Feavers I. M. Identification of meningococcal serosubtypes by polymerase chain reaction. J Clin Microbiol. 1992 Nov;30(11):2835–2841. doi: 10.1128/jcm.30.11.2835-2841.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maiden M. C., Suker J., McKenna A. J., Bygraves J. A., Feavers I. M. Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol Microbiol. 1991 Mar;5(3):727–736. doi: 10.1111/j.1365-2958.1991.tb00743.x. [DOI] [PubMed] [Google Scholar]
- McGuinness B. T., Lambden P. R., Heckels J. E. Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol. 1993 Feb;7(4):505–514. doi: 10.1111/j.1365-2958.1993.tb01141.x. [DOI] [PubMed] [Google Scholar]
- McGuinness B., Barlow A. K., Clarke I. N., Farley J. E., Anilionis A., Poolman J. T., Heckels J. E. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity. J Exp Med. 1990 Jun 1;171(6):1871–1882. doi: 10.1084/jem.171.6.1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyer T. F., Frosch M., Gibbs C. P., Haas R., Halter R., Pohlner J., van Putten J. P. Virulence functions and antigen variation in pathogenic Neisseriae. Antonie Van Leeuwenhoek. 1988;54(5):421–430. doi: 10.1007/BF00461860. [DOI] [PubMed] [Google Scholar]
- Nurminen M., Butcher S., Idänpän-Heikkilä I., Wahlström E., Muttilainen S., Runeberg-Nyman K., Sarvas M., Mäkelä P. H. The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity. Mol Microbiol. 1992 Sep;6(17):2499–2506. doi: 10.1111/j.1365-2958.1992.tb01426.x. [DOI] [PubMed] [Google Scholar]
- Peltola H. Meningococcal disease: still with us. Rev Infect Dis. 1983 Jan-Feb;5(1):71–91. doi: 10.1093/clinids/5.1.71. [DOI] [PubMed] [Google Scholar]
- Poolman J. T., Kriz-Kuzemenska P., Ashton F., Bibb W., Dankert J., Demina A., Frøholm L. O., Hassan-King M., Jones D. M., Lind I. Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin Diagn Lab Immunol. 1995 Jan;2(1):69–72. doi: 10.1128/cdli.2.1.69-72.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poolman J. T., van der Ley P. A., Wiertz E. J., Hoogerhout P. Second generation meningococcal OMP-LPS vaccines. NIPH Ann. 1991 Dec;14(2):233–241. [PubMed] [Google Scholar]
- Scholten R. J., Kuipers B., Valkenburg H. A., Dankert J., Zollinger W. D., Poolman J. T. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J Med Microbiol. 1994 Oct;41(4):236–243. doi: 10.1099/00222615-41-4-236. [DOI] [PubMed] [Google Scholar]
- Sierra G. V., Campa H. C., Varcacel N. M., Garcia I. L., Izquierdo P. L., Sotolongo P. F., Casanueva G. V., Rico C. O., Rodriguez C. R., Terry M. H. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 1991 Dec;14(2):195–210. [PubMed] [Google Scholar]
- Suker J., Feavers I. M., Achtman M., Morelli G., Wang J. F., Maiden M. C. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol. 1994 Apr;12(2):253–265. doi: 10.1111/j.1365-2958.1994.tb01014.x. [DOI] [PubMed] [Google Scholar]
- Suker J., Feavers I. M., Maiden M. C. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design. Microbiology. 1996 Jan;142(Pt 1):63–69. doi: 10.1099/13500872-142-1-63. [DOI] [PubMed] [Google Scholar]
- Tsai C. M., Frasch C. E., Mocca L. F. Five structural classes of major outer membrane proteins in Neisseria meningitidis. J Bacteriol. 1981 Apr;146(1):69–78. doi: 10.1128/jb.146.1.69-78.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Der Ley P., Poolman J. T. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect Immun. 1992 Aug;60(8):3156–3161. doi: 10.1128/iai.60.8.3156-3161.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Virji M., Saunders J. R., Sims G., Makepeace K., Maskell D., Ferguson D. J. Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin. Mol Microbiol. 1993 Dec;10(5):1013–1028. doi: 10.1111/j.1365-2958.1993.tb00972.x. [DOI] [PubMed] [Google Scholar]
- Wedege E., Dalseg R., Caugant D. A., Poolman J. T., Frøholm L. O. Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins. J Med Microbiol. 1993 Jan;38(1):23–28. doi: 10.1099/00222615-38-1-23. [DOI] [PubMed] [Google Scholar]
- Zollinger W. D., Moran E. Meningococcal vaccines--present and future. Trans R Soc Trop Med Hyg. 1991;85 (Suppl 1):37–43. doi: 10.1016/0035-9203(91)90339-z. [DOI] [PubMed] [Google Scholar]
- van der Ley P., Heckels J. E., Virji M., Hoogerhout P., Poolman J. T. Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun. 1991 Sep;59(9):2963–2971. doi: 10.1128/iai.59.9.2963-2971.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]